Menthol Patch Recall Due to Manufacturing Quality Deviations
HealthWise Menstrual Pain Relief Patch (Menthol 10%) is recalled due to manufacturing quality deviations. The firm-initiated recall affects 10,368 patches distributed nationwide in the US.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall with no reported illnesses, injuries, or hospitalizations. The hazard is a manufacturing process deviation without reported product-specific harm, fitting the rubric criterion for voluntary precautionary recalls.
Plain-English summary
HealthWise Menstrual Pain Relief Patch (Menthol 10%) manufactured by Unexo Life Sciences Private Limited was recalled due to current Good Manufacturing Practice (cGMP) deviations. The patches are a topical menthol product marketed for menstrual pain relief.
The recall affected 10,368 patches with UPC 8 45717 01072 6 that had been distributed nationwide in the United States. The product was manufactured for Veridian Healthcare, LLC in Gurnee, Illinois.
Consumers who purchased this product should stop using it and consult their healthcare provider or retailer. No illnesses or injuries have been reported in connection with this recall.
This voluntary, firm-initiated recall was announced on October 24, 2024 and concluded on September 16, 2025.
The recalled product
- Product
- HEALTHWISE MENSTRUAL PAIN RELIEF PATCH (MENTHOL)
- Brand
- HEALTHWISE MENSTRUAL PAIN RELIEF PATCH
- Manufacturer
- Unexo Life Sciences Private Limited
- Category
- Drug — Topical Pain Relief
- Hazard
- manufacturing-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- UPC 8 45717 01072 6
UPCs (1)
- 845717010726
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27